| Prevalence of Post-COVID Condition 12 Weeks After Omicron Infection Compared With Negative Controls and Association With Vaccination Status | Clinical infectious diseases |  | | 2023 | 173 | 283 |
|
| SARS-CoV-2 N501Y introductions and transmissions in Switzerland from beginning of october 2020 to february 2021-implementation of swiss-wide diagnostic screening and whole genome sequencing | Microorganisms | | | 2021 | 247 | 401 |
|
| Toscana virus meningitis case in Switzerland: an example of the ezVIR bioinformatics pipeline utility for the identification of emerging viruses | Clinical microbiology and infection | | | 2015 | 758 | 299 |
|
| Influenza vaccination given at least 2 weeks before delivery to pregnant women facilitates transmission of seroprotective influenza-specific antibodies to the newborn | The Pediatric infectious disease journal |  | | 2013 | 732 | 3 |
|
| Responses of solid organ transplant recipients to the AS03-adjuvanted pandemic influenza vaccine | Antiviral therapy | | | 2012 | 657 | 6 |
|
| Higher memory responses in HIV-infected and kidney transplanted patients than in healthy subjects following priming with the pandemic vaccine | PloS one | | | 2012 | 779 | 368 |
|
| Strong serological responses and HIV RNA increase following AS03-adjuvanted pandemic immunization in HIV-infected patients | HIV medicine | | | 2012 | 728 | 0 |
|
| A prospective study of the factors shaping antibody responses to the AS03-adjuvanted influenza A/H1N1 vaccine in cancer outpatients | The oncologist | | | 2012 | 699 | 0 |
|
| Protective antibody responses to influenza A/H1N1/09 vaccination in children with celiac disease | Journal of pediatric gastroenterology and nutrition | | | 2012 | 642 | 488 |
|
| Graft-versus-host disease is the major determinant of humoral responses to the AS03-adjuvanted influenza A/09/H1N1 vaccine in allogeneic hematopoietic stem cell transplant recipients | Haematologica | | | 2011 | 1,058 | 683 |
|
| Antibody responses to natural influenza A/H1N1/09 disease or following immunization with adjuvanted vaccines, in immunocompetent and immunocompromised children | Vaccine | | | 2011 | 653 | 0 |
|
| Impact of synthetic and biologic disease-modifying antirheumatic drugs on antibody responses to the AS03-adjuvanted pandemic influenza vaccine: a prospective, open-label, parallel-cohort, single-center study | Arthritis and rheumatism | | | 2011 | 886 | 8 |
|
